169 related articles for article (PubMed ID: 31227086)
1. Teaching non-FDA approved nonprescription products: Educating students about potential risks and liability.
Van Dusen V; Pray WS
Curr Pharm Teach Learn; 2019 Jul; 11(7):655-657. PubMed ID: 31227086
[TBL] [Abstract][Full Text] [Related]
2. Taking an alternative risk.
Sveska KJ
Mich Health Hosp; 1998; 34(6):26-7. PubMed ID: 10187139
[TBL] [Abstract][Full Text] [Related]
3. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
4. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
5. Legal and regulatory developments of the 1990s in oral care products: learning from what has come before.
O'Reilly JT
J Public Health Dent; 1992; 52(6):396-400. PubMed ID: 1432936
[TBL] [Abstract][Full Text] [Related]
6. New OTC drugs and devices 2003: a selective review.
Newton GD; Pray WS; Popovich NG
J Am Pharm Assoc (2003); 2004; 44(2):211-25. PubMed ID: 15098853
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
8. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
Fed Regist; 1998 Apr; 63(77):19799-802. PubMed ID: 10179316
[TBL] [Abstract][Full Text] [Related]
9. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
Gibson JE; Taylor DA
J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
[TBL] [Abstract][Full Text] [Related]
11. Opinion of community pharmacists on use of nonprescription medications in Alexandria, Egypt.
Elhoseeny TA; Ibrahem SZ; Abo el Ela AM
J Egypt Public Health Assoc; 2013 Aug; 88(2):79-84. PubMed ID: 23963086
[TBL] [Abstract][Full Text] [Related]
12. A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches.
Fisher M; Rawal K
Ther Innov Regul Sci; 2023 Sep; 57(5):1074-1080. PubMed ID: 37357243
[TBL] [Abstract][Full Text] [Related]
13. Child-resistant packaging for certain over-the-counter drug products. Final rule.
Consumer Product Safety Commission
Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555
[TBL] [Abstract][Full Text] [Related]
14. New OTC drugs and devices 2001: a selective review.
Newton GD; Benninghoff AJ; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2002; 42(2):267-77. PubMed ID: 11926667
[TBL] [Abstract][Full Text] [Related]
15. New OTC drugs and devices 2000: a selective review.
Newton GD; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2001; 41(2):273-82. PubMed ID: 11297337
[TBL] [Abstract][Full Text] [Related]
16. Over-the-counter medications and self-care.
Lowe NK; Ryan-Wenger NM
Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
[TBL] [Abstract][Full Text] [Related]
17. Are non-prescription medications needed for weight control?
Bray GA
Obesity (Silver Spring); 2008 Mar; 16(3):509-14. PubMed ID: 18239604
[TBL] [Abstract][Full Text] [Related]
18. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
[TBL] [Abstract][Full Text] [Related]
19. New OTC drugs and devices 1999: a selective review.
Newton GD; McCullough JA; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2000; 40(2):222-33. PubMed ID: 10730023
[TBL] [Abstract][Full Text] [Related]
20. FDA regulation of OTC oral health care drug products.
Rippere JL
J Public Health Dent; 1992; 52(6):329-32. PubMed ID: 1432917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
